{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Faced with the loss of patent protection for its antidepressant Effexor XR, Wyeth received federal approval for a follow-on drug, Pristiq, that the company hopes will also become a blockbuster.", "headline": {"main": "Wyeth Antidepressant Is Approved"}, "abstract": null, "print_page": null, "word_count": "663", "_id": "547e972b7988107cec11ba03", "snippet": "Faced with the loss of patent protection for its antidepressant Effexor XR, Wyeth received federal approval for a follow-on drug, Pristiq, that the company hopes will also become a blockbuster.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/02/29/business/29cnd-wyeth.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Wyeth", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "Antidepressants", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Inventions and Patents", "is_major": "N", "rank": "4", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Stephanie", "lastname": "SAUL"}], "original": "By STEPHANIE SAUL"}, "document_type": "article", "pub_date": "2008-02-29T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 1, "offset": 0, "time": 57}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}